Kidneys from organ donors who were diagnosed with COVID-19 are safe to transplant and don't transmit the virus to people who receive those organs, according to a new study led by researchers at Washington University School ...
Jun 12, 2023
0
73
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with systemic autoimmune diseases do as well after lung or heart-lung transplants as those without ...
Nov 2, 2021
0
3
A survey of nearly 50,000 cancer survivors has found that more than a quarter had a physical disability that impaired their mobility and almost 10% had a disability affecting self-care, Dana-Farber Cancer Institute researchers ...
Apr 5, 2024
0
24
During the first two years of the COVID-19 pandemic, a flurry of studies made it into the news cycle: Heavy drinking and alcohol-related deaths were spiking in the U.S.
Aug 31, 2022
0
8
A new study at Columbia University Mailman School of Public Health highlights disparities in fine particulate matter (PM2.5) trends between American Indian (AI) and non-AI populated counties of the U.S. PM2.5 is one of several ...
Mar 23, 2022
0
2
A recent poll conducted by University of Michigan researchers found 71% of the 2,000 or so Americans surveyed (aged between 50-80 years) said they had religious beliefs that were important to them.
Feb 20, 2023
0
61
An analysis of national health data in the United States has found that insulin rationing is common among those living with diabetes, especially among older adults and the uninsured. Limiting Medicare copays to $35 a month ...
Oct 17, 2022
0
17
In its latest clinical practice guideline on evaluation and treatment of asthma, an American Thoracic Society expert guidelines panel has addressed the use of fractional exhaled nitric oxide (FeNO) to guide the treatment ...
Nov 17, 2021
0
2
It's a nightmare for parents. The United States is in the grip of a severe shortage of baby formula—with a mass product recall aggravating pandemic supply chain woes—sending families on sometimes desperate hunts for the ...
May 12, 2022
0
19
Pfizer Inc. announced Tuesday that it has launched a Phase 2/3 clinical trial of its COVID antiviral pill known as Paxlovid in children ages 6-17.
Mar 9, 2022
0
18
